Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01603212
Title Systemic Therapy With Interferon, Interleukin-2 and BRAF Inhibitor
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

melanoma

Therapies

Aldesleukin + Alpha 2 Interferon + Vemurafenib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field